Pharmacists in Hayward, Wisconsin


13 Pharmacists found in Hayward
female pharmacist

Allison Farley, PHARMD


Pharmacist
11040 N State Rd 77, Hayward, WI 54843
715-934-4230    

male pharmacist

Dr. Andrew Seidlitz, PHARMD


Pharmacist
10489 State Road 27, Hayward, WI 54843
715-634-1919     715-634-1925

male pharmacist

Franklin G Suo, R.PH.


Pharmacist
13380 W Trepania Rd, Hayward, WI 54843
715-638-5146    



male pharmacist

Gary S Inhoff, R.PH.


Pharmacist
10489 State Road 27, Hayward, WI 54843
715-634-1919     715-634-1925

male pharmacist

James R Strunk, RPH


Pharmacist
13380 W Trepania Rd, Hayward, WI 54843
715-638-5100     715-634-6107

male pharmacist

John W Burns, RPH


Pharmacist
11134n State Highway 77, Suite A, Hayward, WI 54843
715-634-6774     715-634-5517

female pharmacist

Karen Morse


Pharmacist
13380 W Trepania Rd, Hayward, WI 54843
715-638-5147    

female pharmacist

Kelsey Kreyer, PHARMD


Pharmacist
15594 State Hwy 77, Hayward, WI 54843
715-634-8309    

female pharmacist

Leah Pechacek


Pharmacist
15594 State Highway 77, Hayward, WI 54843
715-634-8309    

male pharmacist

Matthew Duane Leblanc, PHARMD


Pharmacist
11040 N State Road 77, Hayward, WI 54843
715-934-4230     715-934-4278

male pharmacist

Michael Laird, PHARMD


Pharmacist
11040 N State Road 77, Hayward, WI 54843
715-934-4230     715-934-4278

male pharmacist

Dr. Ryan Sanok, PHARMD


Pharmacist
10489 State Road 27, Hayward, WI 54843
715-634-1919    

male pharmacist

Thomas L. Blumenberg, R.PH., MPH


Pharmacist
10718 N Clear Lake Dr, Hayward, WI 54843
715-462-4821    


Type of Pharmacists:
Psychiatric Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in optimizing care of patients with psychiatric illness by assessing and monitoring patients, recognizing drug-induced problems, and recommending appropriate treatment plans.
Oncology Pharmacist: A licensed pharmacist who has demonstrated specialized knowledge and skill in developing, recommending, implementing, monitoring, and modifying pharmacotherapeutic plans to optimize outcomes in patients with malignant diseases.